Cellular senescence: Many roads, one final destination

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 727-741

  Saab, Raya ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

DNA damage; Heterochromatin; Oncogene; p53; Rb; Senescence; Tumor suppression

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; PROTEIN P53; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN;

CANCER GROWTH; CANCER INHIBITION; CELL AGING; CELL CYCLE; CHROMATIN CONDENSATION; DNA DAMAGE; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; POSITIVE FEEDBACK; PRECANCER; PRESSOR RESPONSE; SHORT SURVEY; TELOMERE;

CELL AGING; DNA DAMAGE; HUMANS; NEOPLASMS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 77952921902     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.68     Document Type: Short Survey

References (102)

1. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
2. Allsopp, R.C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W., and Harley, C.B. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89(21), 10114-10118.
3. Stein, G.H. and Atkins, L. (1986) Membrane-associated inhibitor of DNA synthesis in senescent human diploid fibroblasts: characterization and comparison to quiescent cell inhibitor. Proc. Natl. Acad. Sci. U. S. A. 83(23), 9030-9034.
4. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., and Lowe, S.W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5), 593-602. (Pubitemid 27152402)
5. te Poele, R.H., Okorokov, A.L., Jardine, L., Cummings, J., and Joel, S.P. (2002) DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62(6), 1876-1883.
6. Chen, Z., Trotman, L.C., Shaffer, D., Lin, H.K., Dotan, Z.A., Niki, M., Koutcher, J.A., Scher, H.I., Ludwig, T., Gerald, W., Cordon-Cardo, C., and Pandolfi, P.P. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436(7051), 725-730. (Pubitemid 41117277)
7. Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z.Q., Lee, S.W., and Aaronson, S.A. (2002) Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 21(9), 2180-2188. (Pubitemid 34516777)
8. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., Benguria, A., Zaballos, A., Flores, J.M., Barbacid, M., Beach, D., and Serrano, M. (2005) Tumour biology: senescence in premalignant tumours. Nature 436(7051), 642. (Pubitemid 41117258)
9. Beausejour, C.M., Krtolica, A., Galimi, F., Narita, M., Lowe, S.W., Yaswen, P., and Campisi, J. (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22(16), 4212-4222. (Pubitemid 37021749)
10. Saab, R., Rodriguez-Galindo, C., Matmati, K., Rehg, J.E., Baumer, S.H., Khoury, J.D., Billups, C., Neale, G., Helton, K.J., and Skapek, S.X. (2009) p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor. Cancer Res. 69(2), 440-448.
11. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., and Pereira-Smith, O. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92(20), 9363-9367.
12. Kurz, D.J., Decary, S., Hong, Y., and Erusalimsky, J.D. (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 113(Pt 20), 3613-3622.
13. Lee, B.Y., Han, J.A., Im, J.S., Morrone, A., Johung, K., Goodwin, E.C., Kleijer, W.J., DiMaio, D., and Hwang, E.S. (2006) Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5(2), 187-195.
14. Cristofalo, V.J. (2005) SA beta Gal staining: biomarker or delusion. Exp. Gerontol. 40(10), 836-838.
15. Narita, M., Nunez, S., Heard, E., Narita, M., Lin, A.W., Hearn, S.A., Spector, D.L., Hannon, G.J., and Lowe, S.W. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113(6), 703-716. (Pubitemid 36724935)
16. Funayama, R. and Ishikawa, F. (2007) Cellular senescence and chromatin structure. Chromosoma 116(5), 431-440.
17. Olsen, C.L., Gardie, B., Yaswen, P., and Stampfer, M.R. (2002) Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene 21(41), 6328-6339.
18. Zhu, J., Woods, D., McMahon, M., and Bishop, J.M. (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12(19), 2997-3007. (Pubitemid 28469302)
19. Parry, D., Bates, S., Mann, D.J., and Peters, G. (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14(3), 503-511.
20. Fridman, A.L. and Tainsky, M.A. (2008) Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene 27(46), 5975-5987.
21. Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., and Lowe, S.W. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14(16), 2015-2027. (Pubitemid 30637352)
22. Shelton, D.N., Chang, E., Whittier, P.S., Choi, D., and Funk, W.D. (1999) Microarray analysis of replicative senescence. Curr. Biol. 9(17), 939-945.
23. Mallette, F.A., Gaumont-Leclerc, M.F., and Ferbeyre, G. (2007) The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 21(1), 43-48. (Pubitemid 46089705)
24. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C.L., Dyrskjot, L., Orntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T.D., Bartek, J., and Gorgoulis, V.G. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444(7119), 633-637.
25. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre', M., Nuciforo, P.G., Bensimon, A., Maestro, R., Pelicci, P.G., and d'Adda di Fagagna, F. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444(7119), 638-642.
26. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J.M., Lukas, C., Orntoft, T., Lukas, J., and Bartek, J. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434(7035), 864-870.
27. Rodier, F., Coppe, J.P., Patil, C.K., Hoeijmakers, W.A., Munoz, D.P., Raza, S.R., Freund, A., Campeau, E., Davalos, A.R., and Campisi, J. (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11(8), 973-979.
28. Gorgoulis, V.G., Vassiliou, L.V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R.A., Jr., Kastrinakis, N.G., Levy, B., Kletsas, D., Yoneta, A., Herlyn, M., Kittas, C., and Halazonetis, T.D. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434(7035), 907-913. (Pubitemid 40559004)
29. Efeyan, A., Murga, M., Martinez-Pastor, B., Ortega-Molina, A., Soria, R., Collado, M., Fernandez-Capetillo, O., and Serrano, M. (2009) Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression. PLoS One 4(5), e5475.
30. Acosta, J.C., O'Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., Takatsu, Y., Melamed, J., d'Adda di Fagagna, F., Bernard, D., Hernando, E., and Gil, J. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133(6), 1006-1018.
31. Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., and Peeper, D.S. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133(6), 1019-1031.
32. Coppe, J.P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.Y., and Campisi, J. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6(12), 2853-2868.
33. Parrinello, S., Coppe, J.P., Krtolica, A., and Campisi, J. (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118(Pt 3), 485-496.
34. Wajapeyee, N., Serra, R.W., Zhu, X., Mahalingam, M., and Green, M.R. (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132(3), 363-374.
35. Acosta, J.C., O'Loghlen, A., Banito, A., Raguz, S., and Gil, J. (2008) Control of senescence by CXCR2 and its ligands. Cell Cycle 7(19), 2956-2959.
36. Ancrile, B., Lim, K.H., and Counter, C.M. (2007) Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 21(14), 1714-1719.
37. Sparmann, A. and Bar-Sagi, D. (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6(5), 447-458.
38. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., and Lowe, S.W. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445(7128), 656-660.
39. Lowy, D.R. and Willumsen, B.M. (1993) Function and regulation of ras. Annu. Rev. Biochem. 62, 851-891.
40. Lin, A.W., Barradas, M., Stone, J.C., van Aelst, L., Serrano, M., and Lowe, S.W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12(19), 3008-3019.
41. Deora, A.A., Win, T., Vanhaesebroeck, B., and Lander, H.M. (1998) A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress. J. Biol. Chem. 273(45), 29923-29928.
42. Lander, H.M., Ogiste, J.S., Pearce, S.F., Levi, R., and Novogrodsky, A. (1995) Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270(13), 7017-7020.
43. Lander, H.M., Ogiste, J.S., Teng, K.K., and Novogrodsky, A. (1995) p21ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270(36), 21195-21198.
44. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P.J. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275(5306), 1649-1652.
45. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49(17), 4682-4689.
46. Boguski, M.S. and McCormick, F. (1993) Proteins regulating Ras and its relatives. Nature 366(6456), 643-654.
47. McCormick, F. (1989) ras GTPase activating protein: signal transmitter and signal terminator. Cell 56(1), 5-8.
48. Sarkisian, C.J., Keister, B.A., Stairs, D.B., Boxer, R.B., Moody, S.E., and Chodosh, L.A. (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat. Cell Biol. 9(5), 493-505.
49. Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., van der Horst, C.M., Majoor, D.M., Shay, J.W., Mooi, W.J., and Peeper, D.S. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436(7051), 720-724. (Pubitemid 41117276)
50. Sun, P., Yoshizuka, N., New, L., Moser, B.A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, Q., Yamout, M., Dong, M.Q., Frangou, C.G., Yates, J.R., III, Wright, P.E., and Han, J. (2007) PRAK is essential for ras-induced senescence and tumor suppression. Cell 128(2), 295-308. (Pubitemid 46123511)
51. Lazzerini, D.E., Attwooll, C., Pasini, D., and Helin, K. (2005) Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol. Cell. Biol. 25(7), 2660-2672. (Pubitemid 40381630)
52. Palmero, I., Pantoja, C., and Serrano, M. (1998) p19ARF links the tumour suppressor p53 to Ras. Nature 395(6698), 125-126. (Pubitemid 28425643)
53. Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91(5), 649-659. (Pubitemid 27513656)
54. Lee, A.C., Fenster, B.E., Ito, H., Takeda, K., Bae, N.S., Hirai, T., Yu, Z.X., Ferrans, V.J., Howard, B.H., and Finkel, T. (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274(12), 7936-7940. (Pubitemid 129518186)
55. Lee, M.H. and Yang, H.Y. (2003) Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev. 22(4), 435-449.
56. Campaner, S., Doni, M., Hydbring, P., Verrecchia, A., Bianchi, L., Sardella, D., Schleker, T., Perna, D., Tronnersjo, S., Murga, M., Fernandez-Capetillo, O., Barbacid, M., Larsson, L.G., and Amati, B. (2010) Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat. Cell Biol. 12(1), 54-59.
57. Courtois-Cox, S., Genther Williams, S.M., Reczek, E.E., Johnson, B.W., McGillicuddy, L.T., Johannessen, C.M., Hollstein, P.E., MacCollin, M., and Cichowski, K. (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10(6), 459-472. (Pubitemid 44872980)
58. Young, A.P., Schlisio, S., Minamishima, Y.A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., and Kaelin, W.G., Jr. (2008) VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat. Cell Biol. 10(3), 361-369. (Pubitemid 351331024)
59. Alimonti, A., Nardella, C., Chen, Z., Clohessy, J.G., Carracedo, A., Trotman, L.C., Cheng, K., Varmeh, S., Kozma, S.C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H.I., and Pandolfi, P.P. (2010) A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120(3), 681-693.
60. d'Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N.P., and Jackson, S.P. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426(6963), 194-198.
61. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J., and Sedivy, J.M. (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14(4), 501-513. (Pubitemid 38648803)
62. Lee, J.J., Lee, J.H., Ko, Y.G., Hong, S.I., and Lee, J.S. (2010) Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species. Oncogene 29(4), 561-575.
63. Sundaresan, M., Yu, Z.X., Ferrans, V.J., Sulciner, D.J., Gutkind, J.S., Irani, K., Goldschmidt-Clermont, P.J., and Finkel, T. (1996) Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318(Pt 2), 379-382. (Pubitemid 26305933)
64. Leikam, C., Hufnagel, A., Schartl, M., and Meierjohann, S. (2008) Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene 27(56), 7070-7082.
65. Park, H.J., Carr, J.R., Wang, Z., Nogueira, V., Hay, N., Tyner, A.L., Lau, L.F., Costa, R.H., and Raychaudhuri, P. (2009) FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 28(19), 2908-2918.
66. Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A., and Nebreda, A.R. (2007) p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11(2), 191-205. (Pubitemid 46209847)
67. Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S., Tahara, H., Nakayama, K., Nakayama, K.I., Ide, T., Saya, H., and Hara, E. (2006) Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8(11), 1291-1297. (Pubitemid 44660595)
68. Moiseeva, O., Mallette, F.A., Mukhopadhyay, U.K., Moores, A., and Ferbeyre, G. (2006) DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol. Biol. Cell 17(4), 1583-1592. (Pubitemid 44011578)
69. Lee, A.C., Fenster, B.E., Ito, H., Takeda, K., Bae, N.S., Hirai, T., Yu, Z.X., Ferrans, V.J., Howard, B.H., and Finkel, T. (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274(12), 7936-7940. (Pubitemid 129518186)
70. Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., and Campisi, J. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5(8), 741-747. (Pubitemid 36986782)
71. Vaupel, P., Kallinowski, F., and Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49(23), 6449-6465. (Pubitemid 20008770)
72. Fong, G.H. (2009) Regulation of angiogenesis by oxygen sensing mechanisms. J. Mol. Med. 87(6), 549-560.
73. Kaelin, W.G., Jr. and Ratcliffe, P.J. (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30(4), 393-402.
74. Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C., and Semenza, G.L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21(12), 3995-4004. (Pubitemid 32476461)
75. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., Simons, J.W., and Semenza, G.L. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60(6), 1541-1545.
76. Welford, S.M., Bedogni, B., Gradin, K., Poellinger, L., Broome, P.M., and Giaccia, A.J. (2006) HIF1alpha delays premature senescence through the activation of MIF. Genes Dev. 20(24), 3366-3371.
77. Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C., and Schumacker, P.T. (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. U. S. A. 95(20), 11715-11720.
78. Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Hammerling, U., and Schumacker, P.T. (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1(6), 401-408.
79. Brunelle, J.K. Bell, E.L., Quesada, N.M., Vercauteren, K., Tiranti, V., Zeviani, M., Scarpulla, R.C., and Chandel, N.S. (2005) Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1(6), 409-414.
80. Mansfield, K.D., Simon, M.C., and Keith, B. (2004) Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J. Appl. Physiol. 97(4), 1358-1366.
81. Kim, W.Y. and Kaelin, W.G. (2004) Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22(24), 4991-5004.
82. Schofield, C.J. and Ratcliffe, P.J. (2004) Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5(5), 343-354.
83. Kaelin, W.G., Jr. (2008) The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat. Rev. Cancer 8(11), 865-873.
84. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M.E., Wiseman, R.W., Pantazis, P., Giovanella, B.C., Tainsky, M.A., Bradley, A., and Donehower, L.A. (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8(9), 2457-2467.
85. Sage, J., Mulligan, G.J., Attardi, L.D., Miller, A., Chen, S., Williams, B., Theodorou, E., and Jacks, T. (2000) Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14(23), 3037-3050.
86. Paramio, J.M., Segrelles, C., Ruiz, S., Martin-Caballero, J., Page, A., Martinez, J., Serrano, M., and Jorcano, J.L. (2001) The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis. J. Biol. Chem. 276(47), 44203-44211. (Pubitemid 37383994)
87. Ye, X., Zerlanko, B., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., and Adams, P.D. (2007) Definition of pRB-and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol. Cell. Biol. 27(7), 2452-2465. (Pubitemid 46581338)
88. Chan, H.M., Narita, M., Lowe, S.W., and Livingston, D.M. (2005) The p400 E1A-associated protein is a novel component of the p53 ->p21 senescence pathway. Genes Dev. 19(2), 196-201. (Pubitemid 40111114)
89. Funayama, R., Saito, M., Tanobe, H., and Ishikawa, F. (2006) Loss of linker histone H1 in cellular senescence. J. Cell Biol. 175(6), 869-880. (Pubitemid 44969193)
90. Narita, M., Narita, M., Krizhanovsky, V., Nunez, S., Chicas, A., Hearn, S.A., Myers, M.P., and Lowe, S.W. (2006) A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126(3), 503-514. (Pubitemid 44163608)
91. Zhang, R., Poustovoitov, M.V., Ye, X., Santos, H.A., Chen, W., Daganzo, S.M., Erzberger, J.P., Serebriiskii, I.G., Canutescu, A.A., Dunbrack, R.L., Pehrson, J.R., Berger, J.M., Kaufman, P.D., and Adams, P.D. (2005) Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8(1), 19-30.
92. Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Dorken, B., Jenuwein, T., and Schmitt, C.A. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436(7051), 660-665.
93. Nielsen, S.J., Schneider, R., Bauer, U.M., Bannister, A.J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R.E., and Kouzarides, T. (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412(6846), 561-565.
94. Vandel, L., Nicolas, E., Vaute, O., Ferreira, R., Ait-Si-Ali, S., and Trouche, D. (2001) Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21(19), 6484-6494.
95. Zhang, W., Chan, H.M., Gao, Y., Poon, R., and Wu, Z. (2007) BS69 is involved in cellular senescence through the p53-p21Cip1 pathway. EMBO Rep. 8(10), 952-958.
96. Bracken, A.P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Monch, K., Minucci, S., Porse, B.T., Marine, J.C., Hansen, K.H., and Helin, K. (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21(5), 525-530.
97. Cloos, P.A., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., Hansen, K.H., and Helin, K. (2006) The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442(7100), 307-311.
98. Northcott, P.A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D.W., Croul, S., Mack, S., Kongkham, P.N., Peacock, J., Dubuc, A., Ra, Y.S., Zilberberg, K., McLeod, J., Scherer, S.W., Sunil, R.J., Eberhart, C.G., Grajkowska, W., Gillespie, Y., Lach, B., Grundy, R., Pollack, I.F., Hamilton, R.L., Van Meter, T., Carlotti, C.G., Boop, F., Bigner, D., Gilbertson, R.J., Rutka, J.T., and Taylor, M.D. (2009) Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 41(4), 465-472.
99. Gauthier, M.L., Berman, H.K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y.Y., Kerlikowske, K., and Tlsty, T.D. (2007) Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 12(5), 479-491.
100. Jacobs, J.J., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P.M., van Welsem, T., van de Vijver, M.J., Koh, E.Y., Daley, G.Q., and van Lohuizen, M. (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat. Genet. 26(3), 291-299.
101. Vance, K.W., Carreira, S., Brosch, G., and Goding, C.R. (2005) Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65(6), 2260-2268.
102. Coppe, J.P., Desprez, P.Y., Krtolica, A., and Campisi, J. (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118.